Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Editorial [Hot Topic: Plasminogen Activator Inhibitor-1 (Guest Editor: Daniel A. Lawrence)] promotion: free to download

Volume:8   Issue: 9
Pp: 960-961
Daniel A. Lawrence
DOI: 10.2174/138945007781662391

PAI-1 Antagonists: Predictable Indications and Unconventional Applications

Volume:8   Issue: 9
Pp: 962-970
Douglas E. Vaughan, Bart M. De Taeye and Mesut Eren
DOI: 10.2174/138945007781662364

Plasminogen Activator Inhibitor-1 in Vascular Thrombosis

Volume:8   Issue: 9
Pp: 996-1002
Randal J. Westrick and Daniel T. Eitzman
DOI: 10.2174/138945007781662328

Plasminogen Activator Inhibitor-1 and Restenosis

Volume:8   Issue: 9
Pp: 1003-1006
Nadish Garg and William P. Fay
DOI: 10.2174/138945007781662355

PAI-1 as a Target in Kidney Disease

Volume:8   Issue: 9
Pp: 1007-1015
Yufeng Huang and Nancy A. Noble
DOI: 10.2174/138945007781662373

The Plasminogen Activation System in Lung Disease

Volume:8   Issue: 9
Pp: 1016-1029
T. H. Sisson and R. H. Simon
DOI: 10.2174/138945007781662319

PAI-1 - A Potential Therapeutic Target in Cancer

Volume:8   Issue: 9
Pp: 1030-1041
Peter A. Andreasen
DOI: 10.2174/138945007781662346